This web map is part of the Centers for Disease Control and Prevention (CDC) PLACES. It provides model-based estimates of current asthma prevalence among adults aged 18 years and old at county, place, census tract and ZCTA levels in the United States. PLACES is an expansion of the original 500 Cities Project and a collaboration between the CDC, the Robert Wood Johnson Foundation, and the CDC Foundation. Data sources used to generate these estimates include the Behavioral Risk Factor Surveillance System (BRFSS), Census 2020 population counts or Census annual county-level population estimates, and the American Community Survey (ACS) estimates. For detailed methodology see www.cdc.gov/places. For questions or feedback send an email to places@cdc.gov.Measure name used for current asthma is CASTHMA.

This map shows the percent of a weighted number of respondents who answer “yes” both to both of the following questions: “Have you ever been told by a doctor, nurse, or other health professional that you have asthma?” and the question “Do you still have asthma?”As stated by the CDC in the methodology:Asthma prevalence describes the size of a state’s population with asthma as well as the overall asthma prevalence relative to other chronic conditions. The greater the prevalence of asthma, the greater the likelihood of adverse outcomes from asthma including emergency department visits, hospitalizations, and death. Compared with persons without asthma, persons with asthma have more days of activity limitation and missed school and missed work and are more likely to report comorbid depression.Who is included in this survey?Weighted number of respondents to BRFSS (or National Survey of Children’s Health) excluding “don’t know” and “refused” responses to the question “Have you ever been told you have asthma?”Data SourceCDC's 2017 500 Cities ProjectArcGIS Living Atlas of the World contains multiple years of 500 Cities CDC layers, which can be found here. For more information about the methodology, visit https://www.cdc.gov/500cities or contact 500Cities@cdc.gov.

Around 7.7% of Americans have asthma, including 20.2 million adults and 4.6 million children. This study examines asthma mortality trends and disparities across U.S. demographic and geographic groups from 1999 to 2020. A retrospective analysis was conducted using the CDC WONDER database to examine asthma-related deaths in the U.S. from 1999 to 2020. Age-adjusted mortality rates (AAMRs) and crude mortality rates (CMRs) per 100,000 were calculated. Trends and annual percent changes (APCs) were assessed overall and stratified by sex, race, region, and age. From 1999 to 2020, the U.S. recorded 221 161 asthma-related deaths (AAMR: 3.07), mostly in medical facilities. Mortality declined from 1999 to 2018 (APC: −1.53%) but surged from 2018 to 2020 (APC: 28.63%). Females, NH Blacks, and NH American Indians had the highest mortality rates. Older adults (≥65) had the greatest burden, with younger groups showing notable increases post-2018. Rural areas and the West reported slightly higher rates than urban and other regions. Hawaii and the District of Columbia had the highest AAMRs, while Florida and Nevada had the lowest. Asthma-related mortality in the U.S. declined until 2018 but sharply increased from 2018 to 2020, with rises across all demographic groups, regions, and settings. Females, NH Blacks, and older adults consistently had higher mortality rates, while younger age groups showed recent alarming increases. Targeted interventions are urgently needed to address inequities and recent mortality surges.

2011 to present. BRFSS combined land line and cell phone prevalence data. BRFSS is a continuous, state-based surveillance system that collects information about modifiable risk factors for chronic diseases and other leading causes of death. Data will be updated annually as it becomes available. Detailed information on sampling methodology and quality assurance can be found on the BRFSS website (http://www.cdc.gov/brfss). Methodology: http://www.cdc.gov/brfss/factsheets/pdf/DBS_BRFSS_survey.pdf Glossary: https://chronicdata.cdc.gov/Behavioral-Risk-Factors/Behavioral-Risk-Factor-Surveillance-System-BRFSS-H/iuq5-y9ct

Asthma is a common respiratory condition that affects the lungs. The airways in the lungs narrow and well, causing obstruction to the airflow (CDC, 2013; NHS, 2018). For some people asthma is mild, but in severe cases, people can experience life-threatening asthma attacks (Mayo Clinic, 2018). In most cases, the cause of asthma is unknown, and although there is no cure, medication can help control asthma (CDC, 2013). Asthma can develop at any stage of life. Often, in children, asthma can resolve during their teenage years; however, it is usually a long-term illness, especially if it first develops in adulthood (NHS, 2018). Read More

According to Cognitive Market Research, The Global Asthma and COPD Drug market size is USD 34512.2 million in 2023 and will expand at a compound annual growth rate (CAGR) of 5% from 2023 to 2030.

North America Asthma and COPD Drugs held the major market of more than 40% of the global revenue with a market size of USD 13804.88 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030.
Europe Asthma and COPD Drugs accounted for a share of over 30% of the global market size of USD 10353.6 million in 2023.
Asia Pacific Asthma and COPD Drug held the market of more than 23% of the global revenue with a market size of USD 7937.81 million in 2023 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030,
Latin America's Asthma and COPD Drug market of more than 5% of the global revenue with a market size of USD 1725.61 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030.
Middle East and Africa Asthma and COPD Drugs held the major market of more than 2% of the global revenue with a market size of USD 690.24 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030.
Technological developments in new medications by key market players.
Demand for monoclonal antibodies remains higher in the asthma and COPD drug market.
The asthma patients category held the highest asthma and COPD drug market revenue share in 2023.

Increasing Asthma and COPD Incidences to Propel the Market Growth

Growth in the market is aided by rising COPD and asthma incidence and prevalence rates which are anticipated to fuel the market expansion during the forecast period. The need for cutting-edge and effective drugs grows as lifestyles change and environmental variables are the major factors that increase diseases such as asthma and COPD. As a result, rising rates of asthma and COPD disease incidence and prevalence have a beneficial effect on the development of novel treatments as well as the demand for these treatments globally, which drives the market for asthma and COPD medications.

For instance, April 2022, according to the Centres for Disease Control and Prevention (CDC) report, there was a decrease in childhood asthma attacks.5. Despite the fact that asthma is manageable, 50% of children with asthma are thought to have uncontrolled asthma.

(Source: aafa.org/asthma/asthma-facts/)

Advancement in Respiratory Diseases Therapeutics and Rising Healthcare Spending to Fuel the Market Growth

The number of new products introduced to treat chronic obstructive pulmonary disorders is increasing which is estimated to boost the market growth during the forecast period. Globally, the cost of healthcare is rising due to reasons like aging populations, growing rates of chronic illness, and population expansion. People are focusing on health and thus spending money on medication or treatments.

For instance, in August 2023, AstraZeneca exhibited new clinical and real-world data from its premier inhaled biologic and early science respiratory portfolio at the European Respiratory Society (ERS) International Congress 2023. Recent findings from the Fasenra and Tezspire studies show how AstraZeneca biologics are helping patients with severe asthma get into remission.

(Source: www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-data-ers-2023-demonstrate-leadership-transforming-care-across-broad-respiratory-portfolio-inhaled-biologic-medicines.html)

Market Restraints of the Asthma and COPD Drug

Side Effects Related With Respiratory Drugs to Hamper the Market Growth. 

During the projected period, respiratory medication side effects are anticipated to restrain market expansion. Patients with COPD and asthma experience various adverse effects from respiratory medications. Dry mouth, headaches, constipation, an accelerated heartbeat, cramping in the muscles, and trembling are the main adverse effects. Inhaled steroids used to treat asthma can occasionally result in hoarseness and thrush, a yeast infection of the mouth. As a result, medical professionals are increasingly advising patients to try alternative therapies like acupuncture, yoga, relaxation techniques, and herbal and dietary supplements. Throughout the projection period, the market for asthma and COPD medications is anticipated to increase at a slowe...

Users can download data sets and fact sheets regarding youth risk behaviors such as, physical activity, smoking and drug use, and sexual behaviors. Background The Youth Risk Behavior Surveillance System (YRBSS) is a national school-based survey conducted by the Centers for Disease Control and Prevention (CDC), as well as state, territorial, tribal and local surveys conducted by other agencies. YRBSS monitors the health risk behaviors and prevalence rates of obesity and asthma among youth and young adults. Information includes: tobacco, drug and alcohol use, sexual behaviors, dietary behaviors, and physical inactivity. Becaus e not every state participates, data on each individual state is not available. User Functionality Fact sheets are available by sex/ gender and racial/ ethnic group, state vs. national comparisons, and on specific behaviors that are ascertained from the more local surveys. Comprehensive results and publications are also available, and data files and the survey instruments can be downloaded into SPSS, SAS or Access. Data is available on the national, state, county and city levels. Data Notes Participants are students in grades 9-12. YRBSS sta rted in 1991, so data is available for every year since then and trend information is offered. The most recent data is from 2009,and the site does not specify when more recent data will become available. Information on the Methods and a Data User’s Manual are helpful tools in understanding the data.

Top 5 predictive search query terms for asthma and COPD models.

The Youth Risk Behavior Surveillance System (YRBSS) collects information about six types of health-risk behaviors that contribute to the leading causes of death and disability among youth and adults in the United States, including: (1) Behaviors that contribute to unintentional injuries and violence; (2) Sexual behaviors related to unintended pregnancy and sexually transmitting diseases, including HIV infection; (3) Tobacco use; (4) Unhealthy dietary behaviors; and (5) Inadequate physical activity. YRBSS also monitors the prevalence of obesity and asthma. The Youth Risk Behavior Survey is conducted during the spring of odd-numbered years and the results are typically released in the summer of the following year. Participating sites may vary from year to year; refer to the Methods page for guidance from the CDC on best practices for combining data from multiple survey years.

Ireland asthma treatment market is expected to grow at steady rate an impressive rate during the forecast period on account of rising prevalence of asthma, increase in air pollution, rise in number of product launches, increase in number of clinical trials for better clinical and therapeutics for asthma is expected to drive the growth of Ireland asthma treatment market during the forecast period. For instance, according to Center for Disease Control and Prevention (CDC), during the coronavirus pandemic, individuals suffering from moderate to severe asthma were at a greater risk of falling ill with acute respiratory disease

1991-2017. High School Dataset. The Youth Risk Behavior Surveillance System (YRBSS) monitors six categories of priority health behaviors among youth and young adults: 1) behaviors that contribute to unintentional injuries and violence; 2) tobacco use; 3) alcohol and other drug use; 4) sexual behaviors related to unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus (HIV) infection; 5) unhealthy dietary behaviors; and 6) physical inactivity. In addition, YRBSS monitors the prevalence of obesity and asthma and other priority health behaviors.

The Youth Risk Behavior Surveillance System (YRBSS) monitors 6 types of health-risk behaviors that contribute to the leading causes of death and disability among youth and adults, including: behaviors that contribute to unintentional injuries and violence; sexual behaviors that contribute to unintended pregnancy and sexually transmitted diseases (STDs), including HIV infection; alcohol and other drug use; tobacco use; unhealthy dietary behaviors; inadequate physical activity. YRBSS also measures the prevalence of obesity and asthma among youth and young adults. YRBSS includes a national school-based survey conducted by CDC and state, territorial, tribal, and local surveys conducted by state, territorial, and local education and health agencies and tribal governments.

2015-2017. High School Dataset – Including Sexual Orientation. The Youth Risk Behavior Surveillance System (YRBSS) monitors six categories of priority health behaviors among youth and young adults: 1) behaviors that contribute to unintentional injuries and violence; 2) tobacco use; 3) alcohol and other drug use; 4) sexual behaviors related to unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus (HIV) infection; 5) unhealthy dietary behaviors; and 6) physical inactivity. In addition, YRBSS monitors the prevalence of obesity and asthma and other priority health behaviors. This dataset contains national, state, and local data from 2015 that includes two aspects of sexual orientation – sexual identity and sex of sexual contacts. Additional information about the YRBSS can be found at www.cdc.gov/yrbss.

1991-2017. Middle School Dataset. The Youth Risk Behavior Surveillance System (YRBSS) monitors six categories of priority health behaviors among youth and young adults: 1) behaviors that contribute to unintentional injuries and violence; 2) tobacco use; 3) alcohol and other drug use; 4) sexual behaviors related to unintended pregnancy and sexually transmitted infections (STIs), including human immunodeficiency virus (HIV) infection; 5) unhealthy dietary behaviors; and 6) physical inactivity. In addition, YRBSS monitors the prevalence of obesity and asthma and other priority health behaviors.

This is a dataset of over 70,000 United States Census tracts enriched with over 25 demographic and environmental variables. These tracts cover the conterminous United States. The tract-level data were used to calculate and map climate resiliency indices.Data SourcesThis data product were first published in January 2022.United States (US) Census Bureau: American Community Survey (ACS) layers for all demographic and housing variables, TIGER/Line Shapefiles USA 2021 for national roads,US Centers for Disease Control and Prevention (CDC) for Daily Census Tract-Level PM2.5 Concentrations, 2016,US CDC PLACES: Local Data for Better Health for Current Asthma Prevalence,US Forest Service Wildfire Risk to Communities layers for Average Wildfire Exposure Type, Average Wildfire Risk to Homes, Average Housing Density, and Wildfire Hazard Potential.Processing NotesThe polygon features underwent several processing steps as part of the enrichment process. The tools used were dependent on the type of input data.All table joins used the attribute GEOID as a unique identifier for tracts.PM2.5 Concentrations were provided as coordinates for census tract centroids as well as census tract FIPS which was joined to polygon GEOIDs.The Zonal Statistics as Table geoprocessing tool was used on raster data types including Wildfire Exposure Type, Risk to Potential Structures, and Wildfire Hazard Potential inputs. Mean values for these inputs was calculated using the census tract as the zone and the raster as the value. Output was then joined back to the features.The Join Field geoprocessing tool was used with ACS input variables.The Egress Score was derived by intersecting TIGER/Line roads with tract boundaries. Roads were first filtered to include only Primary, Secondary, and Local roads. The number of intersections per tract was counted and normalized by the area of the tract. The inverse of this measure is called "Egress Score" and is used as a proxy for ranking tracts based on the number of routes into or out of each tract.*Note: This measure is intended for planning purposes only and should not be used for tactical decision making.Process OverviewFor every census tract, a Z-score was calculated that compares the value of each variable for the tract to the mean value for all tracts in the same county and is expressed as standard deviation from that mean. The Z-scores were than standardized into breaks ranging from 1 to 5 and averaged to create an overall wildfire resiliency index (WRI) for each tract. The WRIs and methodology were developed in collaboration with partners at the Centers for Disease Control and Prevention, UC Davis Department of Public Health, and the US Forest Service's Fire Lab.The tract Egress Score was derived by intersecting US Census Bureau TIGER/Line feature data with census tract polygon features to generate multipoint features. Because the TIGER/Line data may contain multiple coincident road segments that represent different road names, the multipoint features were dissolved using the unique GEOID and generated as point features. This result was summarized on GEOID and counted. The intersection point counts were joined back to the original tract features using GEOID. The counts were normalized by the area of the tracts and the reciprocal was calculated to get the Egress Score for the tract, higher Egress Score means fewer roads intersecting the tract and greater benefit from the intervention.Related WRI maps include “Where Will Better Air Filtration Improve Wildfire Resilience?”, “Where Will Home Hardening Improve Wildfire Resilience?”, and “Where Will Better Evacuation Routes Improve Wildfire Resilience?”.